Perspective Therapeutics, Inc.CATXNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank14
3Y CAGR-25.7%
5Y CAGR-14.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-25.7%/yr
vs +6.4%/yr prior
5Y CAGR
-14.6%/yr
Recent deceleration
Acceleration
-32.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.24M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $5.47M | -11.5% |
| 2021 | $6.18M | +25.3% |
| 2020 | $4.93M | +8.3% |
| 2019 | $4.56M | +6.8% |
| 2018 | $4.27M | +4.6% |
| 2017 | $4.08M | +4.0% |
| 2016 | $3.92M | - |